Answer
No, eltrombopag’s safety and efficacy in combination with direct-acting antiviral agents approved for chronic hepatitis C have not been established.
Sources for this answer
- Revolade film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 28Document updated
Sources checked